---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Rituximab and Hyaluronidase Human - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/rituximabandhyaluronidasehuman
version: v1
---

# Rituximab and Hyaluronidase Human - NCI

# Rituximab and Hyaluronidase Human

Placeholder slot

(rih-TUK-sih-mab â€¦ HY-al-yoo-RAH-nih-days)

This page contains brief information about rituximab and hyaluronidase human
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Rituxan Hycela

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e5b7e82-f018-4eaf-ae78-d6145a906b20&audience=consumer)

## Use in Cancer

Rituximab and hyaluronidase human is approved to be used alone or with other [drugs](/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=English) to treat:

- **[Chronic lymphocytic leukemia](/Common/PopUps/popDefinition.aspx?id=44846&version=Patient&language=English)** (CLL) in adults. It is used with [fludarabine phosphate](/Common/PopUps/popDefinition.aspx?id=613209&version=Patient&language=English) and [cyclophosphamide](/Common/PopUps/popDefinition.aspx?id=45253&version=Patient&language=English).
- **[Diffuse large B-cell lymphoma](/Common/PopUps/popDefinition.aspx?id=428286&version=Patient&language=English).** It is used with [anthracycline](/Common/PopUps/popDefinition.aspx?id=44916&version=Patient&language=English) chemotherapy in adults whose disease has not been treated.
- **[Follicular lymphoma](/Common/PopUps/popDefinition.aspx?id=428287&version=Patient&language=English).** It is used in adults with follicular lymphoma that:
- Has [relapsed](/Common/PopUps/popDefinition.aspx?id=45866&version=Patient&language=English) or is [refractory](/Common/PopUps/popDefinition.aspx?id=45863&version=Patient&language=English) (does not [respond](/Common/PopUps/popDefinition.aspx?id=44085&version=Patient&language=English) to treatment).
- Has not been treated.
- Has responded to [rituximab](/Common/PopUps/popDefinition.aspx?id=45525&version=Patient&language=English) given together with [chemotherapy](/Common/PopUps/popDefinition.aspx?id=45214&version=Patient&language=English).
- Has not [progressed](/Common/PopUps/popDefinition.aspx?id=44078&version=Patient&language=English) after treatment with chemotherapy.

Rituximab and hyaluronidase human is a form of rituximab that is given as a [subcutaneous](/Common/PopUps/popDefinition.aspx?id=45914&version=Patient&language=English) [injection](/Common/PopUps/popDefinition.aspx?id=44678&version=Patient&language=English). This form can be given in less time than rituximab, which is given as an [infusion](/Common/PopUps/popDefinition.aspx?id=45738&version=Patient&language=English). The subcutaneous form is used only after patients have received one full dose of rituximab by infusion. For more information about rituximab that may apply to rituximab and hyaluronidase human, see the Drug Information Summary for [Rituximab](/about-cancer/treatment/drugs/rituximab).

## More About Rituximab and Hyaluronidase Human

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/789585) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Rituximab and Hyaluronidase Human](https://medlineplus.gov/druginfo/meds/a607038.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Cancer Therapies](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Monoclonal Antibodies](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Rituximab And Hyaluronidase Human](https://www.cancer.gov/research/participate/clinical-trials/intervention/C136821) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
